A novel transcriptomic-based immune classification of soft tissue sarcoma (STS) and its association with molecular characteristics, clinical outcome and response to therapy

被引：1
|
作者：
Petitprez, Florent [1 ]
Chen, Tom Wei-Wu [2 ]
Sun, Cheng-Ming [3 ]
Calderaro, Julien [3 ]
Hsiao, Li-Ping [2 ]
Lacroix, Laetitia [3 ]
Natario, Ivo [3 ]
Toulmonde, Maud [4 ]
Lucchesi, Carlo [4 ]
Laizet, Yec'han [4 ]
Italiano, Antoine [4 ]
de Reynies, Aurelien [5 ]
Sautes-Fridman, Catherine [3 ]
Fridman, Wolf H. [3 ]
机构：
[1] French League Canc, Cordeliers Res Ctr, Paris, France
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Cordeliers Res Ctr, Paris, France
[4] Inst Bergonie, Bordeaux, France
[5] French League Canc, Paris, France
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4045
引用
收藏
页数：2
相关论文
共 10 条
  • [1] Immune classification of soft tissue sarcoma and its association with molecular characteristics, and clinical outcome
    Petitprez, F.
    de Reynies, A.
    Chen, T. W-W.
    Sun, C-M.
    Lacroix, L.
    Adam, J.
    Toulmonde, M.
    Italiano, A.
    Sautes-Fridman, C.
    Fridman, W-H.
    ANNALS OF ONCOLOGY, 2018, 29 : 35 - 35
  • [2] Immune classification of soft tissue sarcoma predicts clinical outcome
    Petitprez, F.
    de Reynies, A.
    Keung, E. Z.
    Chen, T. W-W.
    Sun, C-M.
    Jeng, Y-M.
    Hsiao, L-P.
    Lacroix, L.
    Lucchesi, C.
    Toulmonde, M.
    Burgess, M. A.
    Bolejack, V.
    Reinke, D.
    Lazar, A. J.
    Roland, C. L.
    Wargo, J.
    Italiano, A.
    Sautes-Fridman, C.
    Tawbi, H. A.
    Fridman, W. H.
    ANNALS OF ONCOLOGY, 2019, 30 : 689 - 689
  • [3] A molecular signature predictive of clinical outcome following pazopanib therapy in advanced soft tissue sarcoma
    Huang, P.
    Lee, A.
    McCarthy, F.
    Thway, K.
    Morden, J.
    Messiou, C.
    Daley, F.
    Buus, R.
    Fisher, C.
    Cheang, M.
    Judson, I.
    Jones, R.
    ANNALS OF ONCOLOGY, 2017, 28 : 149 - 149
  • [4] Immune-based classification of soft-tissue sarcoma is associated with clinical outcome and unveils tertiary lymphoid structures as surrogate biomarker for the clinic
    Chen, Wei-Wu Tom
    Petitprez, Florent
    Sun, Cheng-Ming
    Lacroix, Laetitia
    De Reynies, Aurelien
    Italiano, Antoine
    Toulmonde, Maud
    Lucchesi, Carlo
    Laizet, Yec'han
    Sautes-Fridman, Catherine
    Fridman, Wolf Herve
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [5] Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review
    Boulouta, A.
    Kyriazoglou, A.
    Kotsantis, I.
    Economopoulou, P.
    Anastasiou, M.
    Pantazopoulos, A.
    Kyrkasiadou, M.
    Moutafi, M.
    Gavrielatou, N.
    Zazas, E.
    Caglar, C.
    Nixon, I.
    Tolia, M.
    Kavourakis, G.
    Psyrri, A.
    CANCER TREATMENT REVIEWS, 2024, 130
  • [6] Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review
    Kyriazoglou, Anastasios
    Boulouta, Anna
    Kotsantis, Ioannis
    Economopoulou, Panagiota
    Kirkasiadou, Maria
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Moutafi, Myrto
    Gavrielatou, Niki
    Zazas, Evangelos
    Nasiadi, Chrysanthi
    Kavourakis, George John
    Psyrri, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Evaluation of homologous recombination deficiency (HRD) score and immuno-tumor microenvironment (iTME) as biomarkers of soft tissue sarcoma (STS) survival and response to immune checkpoint inhibitor therapy.
    Zhang, Chenlu
    Guo, Xi
    Xu, Fei
    You, Yang
    Wang, Zhiming
    Zhuang, Rongyuan
    Liu, Wenshuai
    Ma, Li-Jie
    Tong, Hanxing
    Zhang, Yong
    Lu, Weiqi
    Liu, Jun
    Zhou, Yuhong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] A novel molecular classification based on efferocytosis-related genes for predicting clinical outcome and treatment response in acute myeloid leukemia
    Zhong, Fangmin
    Yao, Fangyi
    Bai, Qin
    Liu, Jing
    Li, Xiaolin
    Huang, Bo
    Wang, Xiaozhong
    INFLAMMATION RESEARCH, 2024, 73 (11) : 1889 - 1902
  • [9] Tumor response and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).
    Stacchiotti, S.
    Verderio, P.
    Messina, A.
    Morosi, C.
    Ferraro, A.
    Quagliuolo, V.
    Martin, J.
    Comandone, A.
    Grignani, G.
    Picci, P.
    Frustaci, S.
    Gronchi, A.
    Casali, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trials
    Vos, Melissa
    Sleijfer, Stefan
    Litiere, Saskia
    Touati, Nathan
    Duffaud, Florence
    van der Graaf, Winette T.
    Gelderblom, Hans
    ACTA ONCOLOGICA, 2019, 58 (06) : 872 - 879
1